Morgan D Fullerton Selected Research

Therapeutics

5/2024	Myeloid AMPK signaling restricts fibrosis but is not required for metformin improvements during CDAHFD-induced NASH in mice.
5/2015	Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity.
11/2014	Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance.
2/2013	Immunometabolism of AMPK in insulin resistance and atherosclerosis.
1/2013	Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Morgan D Fullerton Research Topics

Disease

22	Insulin Resistance 02/2024 - 09/2009
15	Inflammation (Inflammations) 11/2023 - 09/2011
11	Obesity 01/2023 - 09/2009
9	Type 2 Diabetes Mellitus (MODY) 02/2024 - 12/2011
6	Atherosclerosis 11/2023 - 02/2013
5	Non-alcoholic Fatty Liver Disease 01/2023 - 12/2013
4	Infections 09/2023 - 01/2019
4	Fatty Liver 01/2023 - 09/2009
3	Disease Progression 05/2024 - 06/2020
3	Hypertriglyceridemia 11/2017 - 09/2009
3	Glucose Intolerance 08/2014 - 01/2013
2	Alcoholic Fatty Liver 05/2024 - 01/2019
2	Fibrosis (Cirrhosis) 05/2024 - 01/2019
2	Hyperglycemia 02/2024 - 01/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2022 - 09/2009
2	Metabolic Diseases (Metabolic Disease) 01/2022 - 09/2009
2	Dysbiosis 05/2017 - 03/2015
2	Hyperinsulinism (Hyperinsulinemia) 01/2014 - 01/2013
1	Body Weight (Weight, Body) 05/2024
1	Neoplasms (Cancer) 09/2023
1	Hepatitis C 01/2023
1	Liver Diseases (Liver Disease) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Atherosclerotic Plaque (Atheroma) 11/2021
1	Colitis 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Hyperphagia (Overeating) 01/2020
1	Persistent Infection 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Hypercholesterolemia 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Chronic Disease (Chronic Diseases) 01/2018
1	Endotoxemia 05/2017
1	Weight Loss (Weight Reduction) 12/2015

Drug/Important Bio-Agent (IBA)

13	LipidsIBA 01/2022 - 09/2011
6	AMP-Activated Protein KinasesIBA 05/2024 - 12/2013
6	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2013
6	Insulin (Novolin)FDA Link 09/2022 - 09/2011
6	Fatty Acids (Saturated Fatty Acids)IBA 11/2021 - 12/2011
5	Triglycerides (Triacylglycerol)IBA 09/2022 - 09/2009
4	CholesterolIBA 11/2023 - 01/2018
4	Choline (Choline Chloride)IBA 09/2023 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2011
3	Metformin (Glucophage)FDA LinkGeneric 05/2024 - 12/2013
3	Acetyl-CoA CarboxylaseIBA 01/2022 - 08/2014
3	SalicylatesIBA 11/2021 - 05/2015
3	Blood Glucose (Blood Sugar)IBA 11/2021 - 12/2015
3	Phospholipids (Phosphatides)FDA LinkGeneric 06/2020 - 09/2009
3	Peptidoglycan (Murein)IBA 05/2017 - 09/2011
2	CytokinesIBA 09/2023 - 01/2021
2	Adenosine Monophosphate (AMP)IBA 01/2021 - 01/2019
2	DiglyceridesIBA 01/2019 - 12/2011
2	CeramidesIBA 01/2019 - 08/2014
2	CarbohydratesIBA 01/2019 - 12/2015
2	EnzymesIBA 12/2015 - 09/2011
2	Pattern Recognition ReceptorsIBA 03/2015 - 09/2011
2	Ethanolamine-phosphate cytidylyltransferaseIBA 09/2012 - 09/2009
1	CollagenIBA 05/2024
1	Persistent Organic PollutantsIBA 02/2024
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2024
1	Polychlorinated Dibenzodioxins (TCDD)IBA 02/2024
1	PF-6409577IBA 11/2023
1	Interleukin-4 (Interleukin 4)IBA 09/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Phosphatidylethanolamine N-MethyltransferaseIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Ribavirin (Virazole)FDA LinkGeneric 01/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 09/2022
1	salicylsalicylic acid (salsalate)IBA 11/2021
1	Apolipoproteins E (ApoE)IBA 11/2021
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 11/2021
1	ProdrugsIBA 11/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Sodium Salicylate (Salicylate, Sodium)IBA 01/2021
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2021
1	4- hydroxy- 3- (4- (2- hydroxyphenyl)phenyl)- 6- oxo- 7H- thieno(2,3- b)pyridine- 5- carbonitrileIBA 12/2020
1	Choline KinaseIBA 01/2020
1	Bovine Serum AlbuminIBA 01/2020
1	nobiletinIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 10/2019
1	Liver X ReceptorsIBA 10/2019
1	GangliosidesIBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	CathepsinsIBA 01/2019
1	Coenzyme A (CoA)IBA 01/2019
1	Mevalonic Acid (Mevalonate)IBA 01/2019
1	Apolipoprotein C-IIIIBA 11/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2017
1	LipopolysaccharidesIBA 05/2017
1	Acetylmuramyl-Alanyl-IsoglutamineIBA 05/2017
1	PrebioticsIBA 05/2017
1	ProinsulinIBA 05/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2015

Therapy/Procedure

5	Therapeutics 05/2024 - 01/2013
1	Caloric Restriction 01/2020